Statistics for Ovid therapeutics (id:8220 OVID)

Valuation metrics

Market cap

75.27M

Enterprise value

26.21M

Trailing P/E (ttm)

-1.42

Forward P/E

-2.72

PEG ratio

-2.72

Price/Sales (ttm)

119.16

Price/Book (mrq)

0.99

Enterprise Value/Revenue

41.50

Enterprise Value/EBITDA

-0.40

Overview

Shares outstanding

71.01M

Float

46.51M

Shares short

679.89K

% Held by insiders

0.16%

% Held by institutions

0.56%

Average volume (10 days)

332.44K

Average volume (90 days)

Price summary

52-Week low

0.68

52-Week high

4.10

52-Week change

-207.62%

Beta

0.41

50-Day moving average

1.16

200-Day moving average

2.02

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-7,645.09%

Operational effectiveness

Return on assets

-36.04%

Return on equity

-36.60%

Income statement

Revenue (ttm)

0.01

Revenue per share (ttm)

0.01

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-65,058,180.00

Net income to common (ttm)

-32,501,960.00

Diluted EPS (ttm)

-0.46

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

62.71M

Total cash per share (mrq)

0.88

Total debt (mrq)

15.08M

Total Debt/Equity (mrq)

19.76

Current ratio (mrq)

566.00%

Book value per share (mrq)

1.07

Cash flow

Cash flow statement

-57,858,924.00

Levered free cash flow (LFCF)

-28,366,136.00